Colgate-Palmolive Cash & Equivalents increased by 3.6% to $1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.1%, from $1.11B to $1.34B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 7.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $937.00M | $958.00M | $832.00M | $877.00M | $858.00M | $938.00M | $775.00M | $867.00M | $819.00M | $951.00M | $966.00M | $1.08B | $1.11B | $1.23B | $1.10B | $1.11B | $1.22B | $1.28B | $1.29B | $1.34B |
| QoQ Change | — | +2.2% | -13.2% | +5.4% | -2.2% | +9.3% | -17.4% | +11.9% | -5.5% | +16.1% | +1.6% | +11.7% | +2.9% | +11.2% | -11.2% | +1.5% | +9.3% | +5.3% | +0.7% | +3.6% |
| YoY Change | — | — | — | — | -8.4% | -2.1% | -6.9% | -1.1% | -4.5% | +1.4% | +24.6% | +24.5% | +35.5% | +29.8% | +13.5% | +3.1% | +9.5% | +3.6% | +17.5% | +20.1% |